13F-HR filed by Palo Alto Investors LP
Palo Alto Investors LP filed this 13F-HR for the quarter ended 2014-06-30, filed 2014-08-14, with 42 holding rows worth $1,342,913,000.
- Accession
- 0001306923-14-000006
- Filer
- CIK 1306923
- Filed
- 2014-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2014
A holdings report, 42 entries on the cover page, a total value of $1,342,913,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,342,913,000 with VALUE read as thousands by filing date, 13F file number 028-11013. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INTERMUNE INC | 45884X103 | COM | 5,134,058 | $226,669,000 | thousands by filing date | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 1,213,828 | $107,412,000 | thousands by filing date | |
| CYBERONICS | 23251P102 | COMMON STOCK | 1,715,430 | $107,146,000 | thousands by filing date | |
| CUBIST PHARMACEUTICALS INC | 229678107 | COM | 1,526,916 | $106,609,000 | thousands by filing date | |
| AUXILIUM PHARMACEUTICALS | 05334D107 | COMMON STOCK | 4,854,631 | $97,384,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 915,587 | $56,959,000 | thousands by filing date | |
| ABIOMED INC | 003654100 | COM | 2,207,489 | $55,496,000 | thousands by filing date | |
| VANDA PHARMACEUTICALS INC | 921659108 | COM | 3,240,424 | $52,430,000 | thousands by filing date | |
| STAAR SURGICAL CO COM PAR $0.01 | 852312305 | Stock | 2,599,553 | $43,672,000 | thousands by filing date | |
| SEQUENOM INC COM NEW | 817337405 | COM | 9,810,442 | $37,966,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 915,321 | $37,903,000 | thousands by filing date | |
| KYTHERA BIOPHARMACEUTICALS I | 501570105 | COM | 949,959 | $36,450,000 | thousands by filing date | |
| AMAG PHARMACEUTICALS INC | 00163U106 | COM | 1,614,536 | $33,453,000 | thousands by filing date | |
| ANACOR PHARMACEUTICALS INC | 032420101 | COM | 1,661,612 | $29,460,000 | thousands by filing date | |
| CELLADON CORP | 15117E107 | Cmn | 1,468,300 | $23,522,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 3,634,984 | $21,737,000 | thousands by filing date | |
| QUESTCOR PHARMACEUTICALS INC | 74835Y101 | COM | 218,995 | $20,255,000 | thousands by filing date | |
| NPS PHARMACEUTICALS INC | 62936P103 | COM | 609,300 | $20,137,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 962,101 | $19,223,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 5,180,101 | $18,804,000 | thousands by filing date | |
| MOMENTA PHARMACEUTICALS INC | 60877T100 | COM | 1,455,176 | $17,579,000 | thousands by filing date | |
| SHIRE PLC | 82481R106 | COMMON STOCK-FO | 63,700 | $15,001,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 2,275,603 | $14,496,000 | thousands by filing date | |
| CELGENE CORP | 151020104 | COM | 155,180 | $13,327,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 3,971,576 | $13,265,000 | thousands by filing date | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 777,676 | $13,244,000 | thousands by filing date | |
| Gilead Sciences,Inc. | 375558103 | COM | 154,400 | $12,801,000 | thousands by filing date | |
| ALLERGAN INC | 018490102 | COM | 73,900 | $12,505,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 534,018 | $12,042,000 | thousands by filing date | |
| OREXIGEN THERAPEUTICS INC | 686164104 | COMMON STOCK | 1,931,324 | $11,936,000 | thousands by filing date | |
| QLT INC | 746927102 | COMMON STOCK | 1,887,208 | $11,663,000 | thousands by filing date | |
| ALIGN TECHNOLOGY INC COM | 016255101 | Stock | 176,788 | $9,907,000 | thousands by filing date | |
| MEDIVATION INC | 58501N101 | COM | 122,900 | $9,473,000 | thousands by filing date | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 18,400 | $7,577,000 | thousands by filing date | |
| GERON CORP | 374163103 | COM | 1,259,500 | $4,043,000 | thousands by filing date | |
| REVANCE THERAPEUTICS INC | 761330109 | COM | 91,669 | $3,117,000 | thousands by filing date | |
| XOMA CORP DEL | 98419J107 | COM | 624,900 | $2,868,000 | thousands by filing date | |
| AVEO PHARMACEUTICALS INC | 053588109 | COM | 1,200,800 | $2,197,000 | thousands by filing date | |
| HYPERION THERAPEUTICS INC | 44915N101 | COM | 62,700 | $1,636,000 | thousands by filing date | |
| SOPHIRIS BIO INC F | 83578Q209 | FOREIGN CANADIAN | 292,900 | $656,000 | thousands by filing date | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 123,686 | $591,000 | thousands by filing date | |
| BIOSPECIFICS TECHNOLOGIES | 090931106 | COM | 11,184 | $302,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001306923-14-000006 | this filing | 2014-08-14 | acceptance time not in the bulk data set |